CN107823295A - 栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用 - Google Patents
栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用 Download PDFInfo
- Publication number
- CN107823295A CN107823295A CN201711222773.4A CN201711222773A CN107823295A CN 107823295 A CN107823295 A CN 107823295A CN 201711222773 A CN201711222773 A CN 201711222773A CN 107823295 A CN107823295 A CN 107823295A
- Authority
- CN
- China
- Prior art keywords
- gardenia
- flower
- water elution
- disorder
- freeze
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000019116 sleep disease Diseases 0.000 title claims abstract description 39
- 208000020685 sleep-wake disease Diseases 0.000 title claims abstract description 39
- 230000006872 improvement Effects 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 230000036039 immunity Effects 0.000 title claims abstract description 19
- 235000013402 health food Nutrition 0.000 title claims abstract description 18
- 240000001972 Gardenia jasminoides Species 0.000 title claims 35
- 238000010828 elution Methods 0.000 claims abstract description 55
- 239000000843 powder Substances 0.000 claims abstract description 33
- 238000004108 freeze drying Methods 0.000 claims abstract description 32
- 239000002994 raw material Substances 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 230000000694 effects Effects 0.000 claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 17
- 230000006870 function Effects 0.000 claims abstract description 16
- 239000011347 resin Substances 0.000 claims abstract description 10
- 229920005989 resin Polymers 0.000 claims abstract description 10
- 239000002250 absorbent Substances 0.000 claims abstract description 6
- 230000002745 absorbent Effects 0.000 claims abstract description 6
- 206010027175 memory impairment Diseases 0.000 claims abstract description 5
- 230000002040 relaxant effect Effects 0.000 claims abstract 3
- 244000111489 Gardenia augusta Species 0.000 claims description 75
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 51
- 238000002360 preparation method Methods 0.000 claims description 12
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 8
- 238000002347 injection Methods 0.000 claims description 8
- 239000007924 injection Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 238000009472 formulation Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims description 4
- 230000007423 decrease Effects 0.000 claims description 4
- 241001107098 Rubiaceae Species 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 235000008216 herbs Nutrition 0.000 claims description 3
- 208000013403 hyperactivity Diseases 0.000 claims description 3
- 230000006386 memory function Effects 0.000 claims description 3
- 229930003658 monoterpene Natural products 0.000 claims description 3
- 150000002773 monoterpene derivatives Chemical class 0.000 claims description 3
- 235000002577 monoterpenes Nutrition 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 235000013619 trace mineral Nutrition 0.000 claims description 3
- 239000011573 trace mineral Substances 0.000 claims description 3
- 150000003648 triterpenes Chemical class 0.000 claims description 3
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 claims description 2
- 150000004141 diterpene derivatives Chemical class 0.000 claims description 2
- 229960002179 ephedrine Drugs 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 238000003306 harvesting Methods 0.000 claims description 2
- 239000004530 micro-emulsion Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- MDYZKJNTKZIUSK-UHFFFAOYSA-N tyloxapol Chemical compound O=C.C1CO1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 MDYZKJNTKZIUSK-UHFFFAOYSA-N 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 claims 2
- 230000037182 bone density Effects 0.000 claims 2
- 150000004676 glycans Chemical class 0.000 claims 2
- 235000015097 nutrients Nutrition 0.000 claims 2
- 229920001282 polysaccharide Polymers 0.000 claims 2
- 239000005017 polysaccharide Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 239000007938 effervescent tablet Substances 0.000 claims 1
- 239000012156 elution solvent Substances 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 241000157835 Gardenia Species 0.000 abstract 8
- 241000700159 Rattus Species 0.000 description 21
- 210000004556 brain Anatomy 0.000 description 20
- 230000032683 aging Effects 0.000 description 16
- NLPWBELUEANJAT-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-[2-[3-(3-methyldiazirin-3-yl)propanoylamino]ethyldisulfanyl]propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSCCNC(=O)CCC1(C)N=N1 NLPWBELUEANJAT-UHFFFAOYSA-N 0.000 description 14
- 238000011552 rat model Methods 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 6
- 230000002567 autonomic effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 4
- 238000012347 Morris Water Maze Methods 0.000 description 3
- 208000010340 Sleep Deprivation Diseases 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 239000006286 aqueous extract Substances 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- GIKVSFNAEBQLGB-UHFFFAOYSA-N 5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one Chemical compound C=1C(OC)=CC(OC)=C(C(C=2)=O)C=1OC=2C1=CC(OC)=C(OC)C(OC)=C1 GIKVSFNAEBQLGB-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 229930004069 diterpene Natural products 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- CPCPHNWWTJLXKQ-UHFFFAOYSA-N 3',4',5'-O-trimethyltricetin Chemical compound COC1=C(OC)C(OC)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 CPCPHNWWTJLXKQ-UHFFFAOYSA-N 0.000 description 1
- KMZQTSPTBCTYOF-UHFFFAOYSA-N 3,5,6-trihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromen-4-one Chemical compound OC1=C(OC2=CC=C(C(=C2C1=O)O)O)C1=CC(=C(C(=C1)OC)O)OC KMZQTSPTBCTYOF-UHFFFAOYSA-N 0.000 description 1
- XGIUYVCQIWQCCU-UHFFFAOYSA-N 5,7-dihydroxy-2-(3-hydroxy-4,5-dimethoxyphenyl)-8-methoxychromen-4-one Chemical compound OC1=C(OC)C(OC)=CC(C=2OC3=C(OC)C(O)=CC(O)=C3C(=O)C=2)=C1 XGIUYVCQIWQCCU-UHFFFAOYSA-N 0.000 description 1
- OEZZJTAJYYSQKM-UHFFFAOYSA-N 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-methoxychromen-4-one Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 OEZZJTAJYYSQKM-UHFFFAOYSA-N 0.000 description 1
- WFVABHHWJPWNJJ-UHFFFAOYSA-N 5-hydroxy-2-(3-hydroxy-4,5-dimethoxyphenyl)-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC(O)=C(OC)C(OC)=C1 WFVABHHWJPWNJJ-UHFFFAOYSA-N 0.000 description 1
- QULPQWKDDOBIOC-UHFFFAOYSA-N 5-hydroxy-6,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one Chemical compound COC1=C(OC)C(OC)=CC(C=2OC3=CC(OC)=C(OC)C(O)=C3C(=O)C=2)=C1 QULPQWKDDOBIOC-UHFFFAOYSA-N 0.000 description 1
- FLCVGMVLNHYJAW-UHFFFAOYSA-N 5-hydroxy-7-methoxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC(OC)=C(OC)C(OC)=C1 FLCVGMVLNHYJAW-UHFFFAOYSA-N 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- XJMPAUZQVRGFRE-SCHFUKFYSA-N Gardenoside Natural products O=C(OC)C=1[C@H]2[C@H]([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@@](O)(CO)C=C2 XJMPAUZQVRGFRE-SCHFUKFYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- VAYOSLLFUXYJDT-RDTXWAMCSA-N Lysergic acid diethylamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N(CC)CC)C2)=C3C2=CNC3=C1 VAYOSLLFUXYJDT-RDTXWAMCSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- -1 bergamio Chemical compound 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- IHFBPDAQLQOCBX-UHFFFAOYSA-N hispidulin Chemical compound C=1C(=O)C2=C(O)C(OC)=C(O)C=C2OC=1C1=CC=C(O)C=C1 IHFBPDAQLQOCBX-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- XJMPAUZQVRGFRE-AYDWLWLASA-N methyl (1s,4as,7s,7as)-7-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@](C=C2)(O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJMPAUZQVRGFRE-AYDWLWLASA-N 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用。所制备的栀子花本身是栀子花的花初期的花或花蕾或花盛期的花或花衰期的花的阴干花或晒干花，或所制备的栀子花本身是新鲜栀子花的花初期的花或花蕾或花盛期的花或花衰期的花的冷冻干燥花蕾或冷冻干燥花。所制备栀子花的原料组分本身是上述栀子花总提物上大孔吸附树脂的水洗脱部位或30％乙醇洗脱部位或70％乙醇洗脱部位或95％乙醇洗脱部位或冷冻干燥花蕾的粉末或冷冻干燥花的粉末，上述栀子花制备的原料组分具有改善记忆功能减退功能疗效或改善睡眠障碍功能疗效或润肠通便功能疗效或提高免疫力功能疗效。
Description
技术领域
本发明涉及栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用，属于中医药制备技术领域。
背景技术
栀子花来源主要为茜草科栀子属植物栀子Gardenia jasminoides Ellis.的花或茜草科栀子属所有已知植物的花，更具体为新鲜栀子花的花初期的花或花蕾或花盛期的花或花衰期的花、新鲜栀子花蕾冷冻干燥花蕾或新鲜栀子花冷冻干燥花。栀子花性寒味甘苦，入肺、肝经，可药食用两用。栀子花含黄酮、单萜、二萜、三萜、果胶、鞣质、氨基酸、微量元素等成分类型，特别是黄酮类、单萜类、二萜类和三萜为其花的营养价值成分或活性成分类型，如含藏红花素、栀子苷、栀子花酸A、栀子花酸B、乙酸苄酯、乙酸芳樟酯，特别是黄酮类化合物5，7-dihydroxyl-3′，4′，5′-trimethoxyflavone、5，7，4′-trihydroxyl-6-methoxyflavone、5，7，4′-trihydroxyl-8-methoxyflavone、5，7，3′-trihydroxyl-8，4′，5′-trimethoxyflavone、5-hydroxyl-6，7，3′，4′，5′-pentamethoxyflavone、5，3′-dihydroxyl-7，4′，5′-trimethoxyflavone、5-hydroxyl-7，3′，4′，5′-tetramethoxyflavone、3，5，6，4′-tetrahydroxy-3′，5′-dimethoxyflavone、5，7，3′，4′，5′-pentame-thoxyflavone等。栀子花具有泻火除烦，清热利尿，凉血解毒功效。现代药理研究具有镇静安神、缓解疲劳功能。栀子花为药食两用，加工后成为饭桌上的美味佳肴。人们在栀子开花季节，把新鲜栀子花用水泡茶喝或当蔬菜炒着吃，也有把栀子花和大米一起煮粥吃。栀子花鲜汤、栀子花炒竹笋、栀子花炒韭菜等菜肴不但味道鲜美，颇佳能够起到清热凉血、化痰止咳、宽肠通便的作用。栀子花药用价值和保健作用已被认可，但是泡茶、爆炒、煎煮等传统工艺栀子花都是经过高温烹制营养成分被高温破坏，挥发性营养价值成分容易流失。栀子为江西道地药材，其花在保健食品中应用有待进一步系统研究完善，将有助于地方经济的发展。
发明内容
本发明目的是提供栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用。
本发明采用了下述技术方案。
栀子花原料组分的制备方法如下：
(一)采用冷冻干燥工艺将采摘的新鲜栀子花的花初期的花或花蕾或花盛期的花或花衰期的花置于冰柜温度于零下5℃～零下40℃硬化结冰后，置于冷冻真空干燥机内温度于零下5℃～零下50℃，真空度为1～999pa的条件下，冷冻真空干燥6～48小时，其水分含量小于5％，得新鲜栀子花冷冻干燥的花蕾或冷冻干燥的花。
(二)栀子花药材粉碎成粗粉，用0-100％乙醇浸泡0.5-2小时，4-12倍量溶剂加热回流提取2-4次，每次1-3小时，过滤，合并滤液。上述滤液与45-80℃减压浓缩得浸膏，用水稀释至0.5-1.5g生药材/ml，直接上大孔吸附树脂AB-8型或D-101型或HPD-400或各种型号大孔吸附树脂富集，依次用水洗脱、30％乙醇水洗脱、70％乙醇水洗脱、95％乙醇水洗脱，得水洗脱部位、30％乙醇水洗脱部位、70％乙醇水洗脱部位、95％乙醇水洗脱部位，各洗脱部位在45-80℃减压回收溶剂至乙醇适量浓度，用冷冻干燥法或喷雾干燥进行干燥，收集冻干粉或喷雾干燥粉，即得。
前述方法制备的栀子花原料组分可用于制备改善睡眠障碍或改善记忆力减退或润肠通便或提高免疫力药物或保健食品。所述药物或保健食品包括口服液、胶囊、片剂、泡腾片、粉针剂、水针剂、注射剂、雾化剂、微乳剂、凝胶剂、纳米制剂或各种已知剂型制剂或各种可接受剂型制剂，所述药物还包括各种单方制剂和复方制剂。
本发明的优点是：提供了栀子花原料组分的制备方法，所得栀子花原料组分可用于制备改善睡眠障碍或改善记忆力减退或润肠通便或提高免疫力药物或保健食品。
提供了栀子花具体新用途和新功效。
发现了栀子的新的药用部位，栀子花的花蕾，特别是冷冻干燥的栀子花的花蕾，其含有未受外界其他因素影响的花蜜。
具体实施方式
下面结合实施例对本发明作进一步描述：
实施例1
新鲜栀子花的冷冻干燥花蕾的制备方法如下：采用冷冻干燥工艺将采摘清洗后的新鲜栀子花的花蕾2000克置于冰柜温度于零下35℃硬化结冰后，置于冷冻真空干燥机内温度于零下45℃，真空度为8pa的条件下，冷冻真空干燥12小时，其水分含量小于5％，得新鲜栀子花冷冻干燥的花蕾。
实施例2
将实例1中得到的新鲜栀子花冷冻干燥的花蕾应用粉碎机打粉，过药典的6号筛，得100目新鲜栀子花冷冻干燥花蕾的粉末。
实施例3
栀子花水洗脱部位、30％乙醇水洗脱部位、70％乙醇水洗脱部位、95％乙醇水洗脱部位的原料组分的制备方法：将实例2中的100目新鲜栀子花冷冻干燥花蕾的粉末，用70％乙醇水或95％乙醇水浸泡1小时，10倍量溶剂加热回流提取3次，每次1.5小时，过滤，合并滤液。上述滤液于45℃减压浓缩得70％乙醇水浸膏或95％乙醇水浸膏，用水混悬70％乙醇水浸膏或95％乙醇水浸膏至0.5-1.2g生药材/ml，经过AB-8型大孔吸附树脂富集，依次用水、30％乙醇水、70％乙醇水、95％乙醇水洗脱，得到各洗脱部位，各洗脱部位在45℃减压回收溶剂至乙醇适量浓度，用冷冻干燥法或喷雾干燥进行干燥，收集冻干粉或喷雾干燥粉，即得栀子花水洗脱部位、30％乙醇水洗脱部位、70％乙醇水洗脱部位、95％乙醇水洗脱部位的原料组分。
实施例4
本发明从动物因素诱发性与生理性脑衰老的记忆力减退出发，将睡眠障碍(SleepDisorder，SD，其使脑部气络异常或紊乱内生毒邪至“毒损脑络”)和Aβ蛋白等多因素引起的生理性脑衰老的记忆力减退相结合，利用睡眠剥夺致睡眠障碍及鼠脑室一次性注射Aβ淀粉样蛋白制作睡眠障碍生理性脑衰老记忆力减退(Sleep Disorder-factors'PhysiologicalBrain Aging Memory Subside，SDPBAMS,)模型，简称SDAD模型。应用睡眠障碍生理性脑衰老记忆力减退(SDAD)模型大鼠对栀子花制备的原料组分为新鲜栀子花冷冻干燥花蕾的粉末及其30％乙醇水洗脱部位、70％乙醇水洗脱部位和95％乙醇水总提取物进行药理活性筛选，通过行为学(Morris水迷宫)测定和生理生化相应指标的测定与检测，实验证实新鲜栀子花冷冻干燥花蕾的粉末及其30％乙醇水洗脱部位、70％乙醇水洗脱部位和95％乙醇水总提取物能使睡眠障碍生理性脑衰老记忆力减退(SDAD)模型大鼠缩短潜伏期、增加过台次数，延长在第四象限逗留时间。同时，新鲜栀子花冷冻干燥花蕾的粉末及其95％乙醇水总提取物能使睡眠障碍生理性脑衰老记忆力减退(SDAD)模型大鼠自主活动减少，从而起到清心除烦，延缓脑衰老，改善睡眠，抗抑郁等多种功能。其对由睡眠障碍和Aβ纤丝形成聚集等多因素引起的睡眠障碍生理性脑衰老的记忆力减退(SDAD)具有辅助改善记忆功能，进一步证实栀子花制备的原料组分具有改善睡眠障碍或改善记忆力减退功能疗效。
1材料
1.1动物 SPF级健康SD雄性大鼠，体质量300-350g，由湖南斯莱克景达实验动物有限公司提供，许可证号：SCXK(湘)2009-0004。饲养条件：温度20-22℃，喂以大鼠标准饲料，自由饮水。
1.2栀子花的原料组分与试剂 由实例1、实例2和实例3得到的栀子花原料组分为100目新鲜栀子花冷冻干燥花蕾的粉末及其95％乙醇水总提取物和95％乙醇水总体物上大孔吸附树脂的30％乙醇水洗脱部位以及70％乙醇水洗脱部位。D-半乳糖(Sigma公司，批号Lot#SLBD5369V)；Aβ1-40(Sigma公司，批号052M4801V)。
1.3仪器 ZS-B型脑立体定位仪、Morris水迷宫视频分析系统(北京众实迪创科技发展有限责任公司)，Forma-86C ULT超低温冰箱(美国赛默飞)，Allegra64R高速冷冻离心机(美国贝克曼库尔特)，UV-1800型紫外-可见分光光度计(日本岛津公司)。
2方法
2.1动物分组和动物模型的建立 将110只健康SD雄性大鼠随机分为空白组、睡眠障碍生理性脑衰老记忆力减退(Sleep Disorder-factors'Physiological Brain AgingMemory Subside，SDAD)模型组、盐酸多奈哌齐组、栀子花95％乙醇水总提取物中剂量组、栀子花95％乙醇水总提取物高剂量组、栀子花30％乙醇水洗脱部位中剂量组、栀子花30％乙醇水洗脱部位高剂量组、栀子花70％乙醇水洗脱部位中剂量组、栀子花70％乙醇水洗脱部位高剂量组、新鲜栀子花冷冻干燥花蕾的粉末中剂量组、新鲜栀子花冷冻干燥花蕾的粉末高剂量组，共11组，每组10只大鼠。
睡眠障碍生理性脑衰老记忆力减退(SDAD)模型的建立：各实验组先利用改良多平台水环境法进行睡眠剥夺3周得睡眠障碍易发生理性脑衰老记忆力减退大鼠。之后，取未死亡状态良好的睡眠障碍易发生理性脑衰老记忆力减退病变大鼠再脑内注射凝聚态Aβ25-35得睡眠障碍生理性脑衰老记忆力减退(SDAD)整体动物模型。
空白组不予处理；模型组与各给药组分别按上述造模方法予以处理。模型组于脑内注射手术前14天开始灌胃2％吐温-80水溶液至手术后7天截止给药，共21天，每天1次。各给药组于睡眠剥夺第2周开始即手术前14天开始连续灌胃给药至手术后7天截止给药，共给药21天，每天1次。
2.2 Morris水迷宫实验 预先在水池里注入清水使水面高出平台1-2cm，水温控制在24士2℃左右。水池内壁涂有黑漆，每次测试前须向水池内加入适量黑色墨水，水池共分为4个象限。将平台放在第四象限中间，在其他三个象限任选一点面向水池池壁将大鼠放入水中，试验历时5天，每天上午每个象限各测试一次，每次测试1min。若大鼠在1min之内尚未找到平台，则将大鼠拿到平台上并使它在上面站15s，若大鼠在l min之内找到平台，也让其在平台上站15s，方结束一次训练，如此训练4天。在第5天，将平台移走，每只大鼠游l min，记录每只大鼠第一次经过原平台的时间(潜伏期)，每只大鼠在l min内经过平台的次数、游过的总距离以及在原平台所在象限及其它三个象限内逗留的时间，计算出在第四象限游泳的时间(t4)占整个游泳时间(t总)的百分比。
2.3自主活动测试：将小动物自主活动检测装置与MP-100生理实验信号采集分析系统相连，随机在每个装置内放1只大鼠，每次检测前让动物在装置内适应5min，检测室内保持安静，防止对大鼠的活动产生影响。记录各组大鼠20min内的自主活动次数和自主活动时间，并称量大鼠的体重变化。
2.4统计方法 采用SAS软件分析，实验数据用x±s表示，单因素方差分析实验的数据。P＜0.05为有统计学意义。
3结果
3.1栀子花原料组分对睡眠障碍生理性脑衰老记忆力减退(SDAD)模型大鼠Morris水迷宫实验的影响
与空白组比较，模型组大鼠潜伏期延长、过台次数减少，在第四象限逗留时间短，差异显著(P＜0.01)；与模型组比较，给药盐酸多奈哌齐组、栀子花原料组分各组能缩短潜伏期、增加过台次数，在第四象限逗留时间和距离延长(P＜0.05或P＜0.01)，说明各给药组治疗有效，提示栀子花原料组分(尤其是栀子花30％乙醇水洗脱部位组、新鲜栀子花冷冻干燥花蕾的粉末组、新鲜栀子花冷冻干燥花蕾粉末的95％乙醇水总提取物组)效果明显，具有改善记忆功能减退的功能疗效。结果见表1。
表1栀子花原料组分各部位对SDAD模型大鼠空间探索试验结果
与模型组比较：*P<0.05，**P<0.01
3.2栀子花原料组分对睡眠障碍生理性脑衰老记忆力减退(SDAD)模型大鼠自主活动行为学试验结果
与空白组比较，模型组大鼠自主活动次数减少(睡眠障碍、心神不宁、焦虑紧张不安、痴呆症状表现，大鼠毛色凌乱、行为焦躁并有一定攻击性)，体重增加缓慢，差异显著(P＜0.01)；与模型组比较，栀子花原料组分各部位能使模型动物的活动次数增加(疏肝和胃、理气解郁、改善睡眠功能、缓解疲劳功能，给药后的大鼠毛色光滑平整、性情温和)，体重增加明显(P＜0.05或P＜0.01)，说明栀子花原料组各部位对SDAD模型大鼠效果明显，尤其是新鲜栀子花冷冻干燥花蕾的粉末和栀子花95％乙醇总提取物效果最优。新鲜栀子花冷冻干燥花蕾的粉末因其含有花粉具有改善胃肠道功能(通便)，特别是青少年多动症、改善胃肠道功能(厌食症)并增加体重。见结果见表2和表3。
表2栀子花原料组分各部位对SDAD模型大鼠自主活动行为学试验结果
与模型组比较：*P<0.05，**P<0.01
表3栀子花原料组分各部位对SDAD模型大鼠体重变化分析结果
Claims (8)
1.栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用，其特征在于：栀子花制备的原料组分本身是栀子花总提物上大孔吸附树脂的水洗脱部位或30％乙醇水洗脱部位或70％乙醇水洗脱部位或95％乙醇水洗脱部位或栀子花粉碎的粉末或栀子花总提取物，上述栀子花制备的原料组分具有改善记忆功能减退或改善睡眠障碍或润肠通便或提高免疫力的功能疗效。
2.根据权利要求1中所述的栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用，其特征在于：栀子花来源主要为茜草科栀子属植物栀子Gardenia jasminoides Ellis.的花或茜草科栀子属所有已知植物的花，更具体为栀子花的花初期的花或花蕾或花盛期的花或花衰期的花的阴干花或晒干花，或新鲜栀子花的花初期的花或花蕾或花盛期的花或花衰期的花的冷冻干燥花蕾或冷冻干燥花。
3.根据权利要求2中所述的栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用，其特征在于：所制备的栀子花本身是新鲜栀子花的花初期的花或花蕾或花盛期的花或花衰期的花的冷冻干燥花蕾或冷冻干燥花，采用冷冻干燥工艺将采摘的新鲜栀子花的花初期的花或花蕾或花盛期的花或花衰期的花置于冰柜温度于零下5℃～零下40℃硬化结冰后，置于冷冻真空干燥机内温度于零下5℃～零下50℃，真空度为1～999pa的条件下，冷冻真空干燥6～48小时，其水分含量小于5％，得新鲜栀子花冷冻干燥的花蕾或冷冻干燥花。
4.根据权利要求1中所述栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用，其特征在于：栀子花原料组分的制备方法，将栀子花药材粉碎成粗粉，用0-100％乙醇浸泡0.5-2小时，4-12倍量溶剂加热回流提取2-4次，每次1-3小时，过滤，合并滤液。上述滤液与45-80℃减压浓缩得浸膏，用水稀释至0.5-1.5g生药材/ml，直接上大孔吸附树脂AB-8型或D-101型或HPD-400或各种型号大孔吸附树脂富集，依次用水洗脱、30％乙醇水洗脱、70％乙醇水洗脱、95％乙醇水洗脱，得水洗脱部位、30％乙醇水洗脱部位、70％乙醇水洗脱部位、95％乙醇水洗脱部位，各洗脱部位在45-80℃减压回收溶剂至乙醇适量浓度，用冷冻干燥法或喷雾干燥进行干燥，收集冻干粉或喷雾干燥粉，即得。
5.根据权利要求1-4中所述栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用，其特征在于：功能疗效为栀子花制备的原料组分为栀子花的花蕾或花盛期的花的阴干花或晒干花粉碎成40-100目的粉末，或新鲜栀子花的花蕾或花盛期的花的冷冻干燥花蕾或冷冻干燥花粉碎成40-100目的粉末，上述栀子花粉末含栀子花花粉或花蜜的主要营养成分，上述栀子花粉末主要含有多糖、氨基酸、微量元素、果胶、黄酮类活性成分、单萜类活性成分(环烯醚萜类活性成分)、二萜类活性成分和三萜类活性成分，上述栀子花粉末具有润肠通便或提高机体免疫力或改善记忆功能减退或改善睡眠障碍的功能疗效，上述栀子花粉末特别适用于治疗青少年多动症或厌食症，上述栀子花粉末具有强壮骨骼并增加骨密度。
6.根据权利要求1-5中所述栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用，其特征在于：栀子花制备的原料组分具有通便或提高免疫力功效，上述栀子花的总提取物上大孔吸附树脂的水洗脱部位，其水洗脱部位含栀子花花粉或花蜜的主要营养成分，其水洗脱部位主要含有多糖、氨基酸、微量元素和果胶，上述水洗脱部位具有润肠通便或提高机体免疫力的功能疗效，上述水洗脱部位特别适用于治疗青少年多动症或厌食症，上述水洗脱部位具有强壮骨骼并增加骨密度。
7.根据权利要求1-5中所述栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用，其特征在于：栀子花制备的原料组分具有改善记忆功能减退或改善睡眠障碍功能疗效，上述栀子花的总提取物及其总提取物上大孔吸附树脂的30％乙醇水洗脱部位或70％乙醇水洗脱部位或95％乙醇水洗脱部位，上述总提取物或30％乙醇水洗脱部位或70％乙醇水洗脱部位或95％乙醇水洗脱部位均具有改善记忆功能减退或改善睡眠障碍的功能疗效。
8.根据权利要求1中所述栀子花制备的原料组分在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用，其特征在于，所述药物或保健食品包括口服液、胶囊、片剂、泡腾片、粉针剂、水针剂、注射剂、雾化剂、微乳剂、凝胶剂、纳米制剂或各种已知剂型制剂或各种可接受剂型制剂，所述药物或保健食品还包括各种单方制剂和复方制剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711222773.4A CN107823295A (zh) | 2017-11-28 | 2017-11-28 | 栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711222773.4A CN107823295A (zh) | 2017-11-28 | 2017-11-28 | 栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107823295A true CN107823295A (zh) | 2018-03-23 |
Family
ID=61646475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711222773.4A Pending CN107823295A (zh) | 2017-11-28 | 2017-11-28 | 栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107823295A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110038054A (zh) * | 2019-05-13 | 2019-07-23 | 江西中医药大学 | 栀子花及枝叶果实中有效部位在制备改善睡眠或抗抑郁或改善记忆力减退药物或食品中应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001049281A2 (en) * | 1999-12-30 | 2001-07-12 | Proteotech, Inc. | POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND α-SYNUCLEIN FIBRIL DISEASES |
| CN107080253A (zh) * | 2017-04-20 | 2017-08-22 | 江西中医药大学 | 栀子花和酸橙花所制备的原料组分在制备各类保健食品中应用 |
-
2017
- 2017-11-28 CN CN201711222773.4A patent/CN107823295A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001049281A2 (en) * | 1999-12-30 | 2001-07-12 | Proteotech, Inc. | POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND α-SYNUCLEIN FIBRIL DISEASES |
| CN107080253A (zh) * | 2017-04-20 | 2017-08-22 | 江西中医药大学 | 栀子花和酸橙花所制备的原料组分在制备各类保健食品中应用 |
Non-Patent Citations (3)
| Title |
|---|
| 吴清柳，等: "栀子治疗中枢神经系统疾病的研究进展", 《海南医学》 * |
| 张家建，等: "栀子花药用价值分析研究", 《浙江中医杂志》 * |
| 王立，等: "栀子中京尼平苷及藏红花素的神经保护作用研究进展", 《中草药》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110038054A (zh) * | 2019-05-13 | 2019-07-23 | 江西中医药大学 | 栀子花及枝叶果实中有效部位在制备改善睡眠或抗抑郁或改善记忆力减退药物或食品中应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230165927A1 (en) | Plant extract highly concentrated in safranal, production method and uses thereof | |
| CN103070061B (zh) | 一种功能型豆芽及其生产方法 | |
| CN107080253A (zh) | 栀子花和酸橙花所制备的原料组分在制备各类保健食品中应用 | |
| CN107648349A (zh) | 代代花在制备改善睡眠障碍或改善记忆力减退或治疗阿尔茨海默病药物或保健食品中的应用 | |
| CN103907707B (zh) | 罗汉果清肺茶及其制备方法 | |
| CN108968071A (zh) | 代代花和火麻仁组合物在制备改善记忆力减退或治疗抑郁症药物或保健功能饮料中的应用 | |
| CN106310120A (zh) | 一种广普型中药组合物水剂及其制备方法 | |
| CN107595990A (zh) | 一种基于栀子花和代代花的不同浓度乙醇水洗脱部位及其中活性成分组合药物及用途 | |
| CN107853517A (zh) | 一种提神抗疲劳的中药饮料及其制备方法 | |
| CN107823295A (zh) | 栀子花在制备改善睡眠障碍或改善记忆力减退或通便或提高免疫力药物或保健食品中应用 | |
| CN107981347A (zh) | 新鲜红花油茶花或白花油茶花及其组合物所制备原料在制备各类茶品或饮料或食品中应用 | |
| CN107635573A (zh) | 特应性皮炎中药制剂、制备方法及其用途 | |
| CN107789562A (zh) | 一种药食同源的组合物在制备改善睡眠障碍或改善记忆功能减退药物或保健食品中的应用 | |
| CN107927765A (zh) | 新鲜葛花及其组合物所制备原料在制备各类茶品或饮料或保健食品中应用 | |
| KR20150118363A (ko) | 혼합 생약제 추출물을 유효성분으로 하는 우울증 예방 및 치료 조성물 및 그의 제조방법 | |
| CN103623109B (zh) | 一种治疗缺血性脑血管病的中药组合物及其制备方法 | |
| CN106490382A (zh) | 一种夏季用肉鸭配合饲料 | |
| CN104905032A (zh) | 防治黄沙鳖肝炎的饲料添加剂 | |
| CN105249456A (zh) | 一种石斛保健组合物 | |
| CN106727245B (zh) | 一种清热保湿护唇膏及其制备方法 | |
| CN103919842A (zh) | 一种大麻药药材的炮制工艺 | |
| CN104027401A (zh) | 一种用于儿童抗病毒、清热消炎的双黄连药物组合及其制备方法 | |
| CN103446307A (zh) | 一种治疗糖尿病足的中药组合物 | |
| CN103784600A (zh) | 增强貉子免疫力的中草药口服液 | |
| CN104082669B (zh) | 降低血液粘稠度的养生粥及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180323 |